{
  "schemaVersion" : 2,
  "registerId" : "F2017C00784",
  "instrumentNumber" : "98/2011",
  "citation" : "Statement of Principles concerning malignant neoplasm of the renal pelvis and ureter No. 98 of 2011",
  "conditionName" : "malignant neoplasm of the renal pelvis and ureter",
  "effectiveFrom" : "2011-08-31",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "C65"
  }, {
    "version" : "ICD-10-AM",
    "code" : "C66"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "smoking at least five pack-years of cigarettes, or the equivalent thereof\r\nin other tobacco products, before the clinical onset of malignant\r\nneoplasm of the renal pelvis or ureter, where smoking commenced at\r\nleast ten years before the clinical onset of malignant neoplasm of the\r\nrenal pelvis or ureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(b)",
    "text" : "having received a cumulative equivalent dose of at least 0.1 sievert of\r\nionising radiation to the affected site at least five years before the\r\nclinical onset of malignant neoplasm of the renal pelvis or ureter",
    "definedTerms" : [ {
      "term" : "cumulative equivalent dose",
      "definition" : "means the total dose of ionising radiation\nreceived by the particular organ or tissue from external exposure, internal\nexposure or both, apart from normal background radiation exposure in\nAustralia, calculated in accordance with the methodology set out in Guide to\ncalculation of 'cumulative equivalent dose' for the purpose of applying\nionising radiation factors contained in Statements of Principles determined\nunder Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian\nRadiation Protection and Nuclear Safety Agency, as in force on 2 August\n2017;\nNote 1: Examples of circumstances that might lead to exposure to ionising radiation include\nbeing present during or subsequent to the testing or use of nuclear weapons,\nundergoing diagnostic or therapeutic medical procedures involving ionising radiation,\nand being a member of an aircrew, leading to increased levels of exposure to cosmic\nradiation.\nNote 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass\nof a specific tissue or organ. If a tissue is exposed to multiple sources of ionising\nradiation, the various dose estimates for each type of radiation must be combined"
    } ]
  }, {
    "paragraph" : "6(c)",
    "text" : "being exposed to arsenic as specified before the clinical onset of\r\nmalignant neoplasm of the renal pelvis or ureter, where the first\r\nexposure to arsenic occurred at least ten years before the clinical onset\r\nof malignant neoplasm of the renal pelvis or ureter",
    "definedTerms" : [ {
      "term" : "being exposed to arsenic as specified",
      "definition" : "means:\n(a) consuming drinking water with an average arsenic concentration of at\nleast 50 micrograms per litre for a cumulative period of at least ten\nyears;\n(b) consuming drinking water resulting in a cumulative total arsenic\nexposure equivalent to having consumed drinking water containing at\nleast 50 micrograms per litre for at least ten years; or\n(c) having clinical evidence of chronic arsenic toxicity"
    } ]
  }, {
    "paragraph" : "6(d)",
    "text" : "ingesting aristolochic acid as specified at least five years before the\r\nclinical onset of malignant neoplasm of the renal pelvis or ureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(e)",
    "text" : "having renal stone disease of the affected urinary tract at least five\r\nyears before the clinical onset of malignant neoplasm of the renal\r\npelvis or ureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(f)",
    "text" : "having hydronephrosis of the affected urinary tract at least five years\r\nbefore the clinical onset of malignant neoplasm of the renal pelvis or\r\nureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(g)",
    "text" : "having a chronic renal condition, of sufficient severity to require\r\ndialysis or renal transplanation, at least one year before the clinical\r\nonset of malignant neoplasm of the renal pelvis or ureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(h)",
    "text" : "consuming a total of at least 100 grams of phenacetin at least five years\r\nbefore the clinical onset of malignant neoplasm of the renal pelvis or\r\nureter",
    "definedTerms" : [ {
      "term" : "phenacetin",
      "definition" : "means an aniline derivative that has analgesic and antipyretic\nproperties, and was formerly used as a constituent of several over-the-counter\ncompound analgesic medications, including Bex or Vincent's powder, Empirin\nCompound and Bromo seltzer. Phenacetin is also known as acetophenetidin,\naceto-p-phenetidide, acetylphenetidin, phenacetinum, N-(4-ethoxyphenyl)\nacetamide, p-ethoxyacetanilide, or CAS 62-44-2"
    } ]
  }, {
    "paragraph" : "6(i)",
    "text" : "being treated with systemic cyclophosphamide or systemic ifosfamide,\r\nat least five years before the clinical onset of malignant neoplasm of\r\nthe renal pelvis or ureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(j)",
    "text" : "inhaling fumes containing high concentrations of polycyclic aromatic\r\nhydrocarbons, or ingesting polycyclic aromatic hydrocarbons, in the\r\nspecified circumstances for a cumulative period of at least 5000 hours\r\nbefore the clinical onset of malignant neoplasm of the renal pelvis or\r\nureter, where the first exposure occurred at least ten years before the\r\nclinical onset of malignant neoplasm of the renal pelvis or ureter",
    "definedTerms" : [ {
      "term" : "polycyclic aromatic hydrocarbons",
      "definition" : "means hydrocarbons with three or\nmore condensed aromatic rings in which certain carbon atoms are common to\ntwo or three rings. A common example is benzo[a]pyrene. Polycyclic aromatic\nhydrocarbons occur in crude oil, shale oil and coal tars, and can be formed\nduring the combustion of organic material or during high temperature\nprocessing of crude oil, coal, coke or other industrial carbon compounds"
    } ]
  }, {
    "paragraph" : "6(k)",
    "text" : "inhaling fumes containing a high concentration of an aromatic amine\r\nfrom the specified list, or ingesting or having cutaneous contact with an\r\naromatic amine from the specified list, for a cumulative period of at\r\nleast 500 days within a continuous period of five years before the\r\nclinical onset of malignant neoplasm of the renal pelvis or ureter,\r\nwhere the first exposure occurred at least ten years before the clinical\r\nonset of malignant neoplasm of the renal pelvis or ureter",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(l)",
    "text" : "working as a painter for a cumulative period of at least 10 000 hours\r\nbefore the clinical onset of malignant neoplasm of the renal pelvis or\r\nureter, and where exposure has ceased, the clinical onset of malignant\r\nneoplasm of the renal pelvis or ureter occurred within 30 years of\r\ncessation",
    "definedTerms" : [ {
      "term" : "working as a painter",
      "definition" : "means applying paints, including solvent- or water-\nbased conventional paints, spray paints, varnishes, enamels, lacquers, water-\nemulsion and solution finishes, nonaqueous dispersions or organosols,\nplastisols, and powder coatings, during the course of activities such as\nbuilding, maintenance and construction, interior and exterior decoration,\nartistic painting, and wood and metal painting. This definition includes mixed\nactivities in which application of paints occurs with other tasks such as\nwallpapering and plastering. This definition includes activities that are\npreparatory to painting, such as mixing paints, maintaining painting\nequipment, and background preparation of surfaces for application of paint"
    } ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(m)",
    "text" : "inability to obtain appropriate clinical management for malignant\r\nneoplasm of the renal pelvis or ureter",
    "definedTerms" : [ ]
  } ]
}